BRIEF published on 05/06/2025 at 14:08, 11 months 27 days ago Zalando SE maintient une forte croissance au premier trimestre 2025 Acquisition Recommandation D'achat Croissance Des Revenus Zalando SE T1 2025
BRIEF published on 05/06/2025 at 14:06, 11 months 27 days ago Tharimmune Reports Positive Phase 1 Results for TH104 Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF published on 05/06/2025 at 14:06, 11 months 27 days ago Tharimmune annonce des résultats positifs de phase 1 pour le TH104 Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago Galimedix Therapeutics Completes Phase 1 Study with GAL-101 Alzheimer's Disease Galimedix Therapeutics GAL-101 Phase 1 Study AMD
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago Galimedix Therapeutics achève l'étude de phase 1 avec GAL-101 Maladie D'Alzheimer Galimedix Therapeutics Étude De Phase 1 GAL-101 DMLA
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago MIRA Pharmaceuticals Announces Absence of Neurotoxicity in Ketamir-2 Study Phase I Trial MIRA Pharmaceuticals Ketamir-2 NMDA Receptor Neurotoxicity Study
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago MIRA Pharmaceuticals annonce l'absence de neurotoxicité dans l'étude Ketamir-2 Essai De Phase I MIRA Pharmaceuticals Ketamir-2 Récepteur NMDA Étude De Neurotoxicité
BRIEF published on 05/06/2025 at 14:05, 11 months 27 days ago Scepter Holdings, Inc. Welcomes Natalie Guzman to Advisory Board Advisory Board Marketing Strategy Scepter Holdings Natalie Guzman Collegiate Athlete Market
Published on 05/02/2026 at 21:00, 15 hours 20 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 10 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 11 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 12 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 12 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 7 hours 35 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 20 hours 45 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 21:21, 2 days 14 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 16 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 16 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 17 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 17 hours ago AXA annonce les résultats de son Assemblée Générale
